OrbiMed’s Health Catalyst HCAT Stock Holding History

OrbiMed’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-179,598	Closed	-$8.4M	–	167
2021 Q1	$8.4M	Hold	179,598	–	–	0.08%	126
2020 Q4	$7.82M	Hold	179,598	–	–	0.07%	129
2020 Q3	$6.57M	Hold	179,598	–	–	0.08%	121
2020 Q2	$5.24M	Hold	179,598	–	–	0.07%	120
2020 Q1	$4.7M	Hold	179,598	–	–	0.08%	108
2019 Q4	$6.23M	Hold	179,598	–	–	0.09%	96
2019 Q3	$5.68M	Buy	+179,598	New	+$7.07M	0.11%	91

Other funds holding HCAT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

OrbiMed's HCAT Position: Q2 2021 in Review

OrbiMed sold out of Health Catalyst (HCAT) in Q2 2021, closing a stake of 179,598 shares — an estimated $8.4M sold.

OrbiMed first reported a position in HCAT in Q3 2019 and held it in 7 quarters. The position peaked at $8.4M in Q1 2021. 198 funds tracked by Wall St. Rank hold HCAT as of Q2 2021.

OrbiMed reported no remaining Health Catalyst position as of Q2 2021 after selling out during the quarter.
OrbiMed sold 179,598 Health Catalyst shares in Q2 2021, an estimated $8.4M.
OrbiMed first reported a position in Health Catalyst in Q3 2019 and held it in 7 quarters.
OrbiMed's Health Catalyst position peaked at $8.4M in Q1 2021.
198 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2021.

Based on OrbiMed's 13F filing for Q2 2021, filed 16 Aug 2021.